Skip to content

Genome & Company

Request correction

Genome & Company is a South Korean company whose website presents a pipeline spanning a GNOCLE™ platform, microbiome assets, and new biologics.

Last updated October 26, 2026

AI crawler reads

1requests

1companies
  • Google1
Profile
1
Controversies
0
JSON · MD
0
First read
Nov 5, 2026
Latest read
Nov 5, 2026

From this site's server log

Overview

Genome & Company (Korean: 지놈앤컴퍼니) is a South Korean company based in Suwon, Gyeonggi-do. Its official website organizes its activities around a Pipeline section that lists a GNOCLE™ platform, Microbiome assets (GEN-001, SB-121), and New biologics (GENA-104, GENA-120, GENA-121, GENA-122). The site also provides Investor Relations, Public Relations, Careers, and Business Development sections.

History

Genome & Company (Korean: 지놈앤컴퍼니) is a South Korean company headquartered in Suwon, Gyeonggi-do. Its official website presents a Pipeline section covering a GNOCLE™ platform, Microbiome assets (GEN-001, SB-121), and New biologics (GENA-104, GENA-120, GENA-121, GENA-122), alongside Investor Relations, Public Relations, Careers, and Business Development sections.

Products and positioning

  • GNOCLE™ platform

  • GEN-001

  • SB-121

  • GENA-104

  • GENA-120

  • GENA-121

  • GENA-122

Recent events

  • Unconfirmed

    Reported

    Genome & Company acquires Allbloom[4]

    Genome & Company acquired K-beauty distributor Allbloom in a move described as expanding its US retail presence.

Read more

Sources4 sources

Cite this profile: Cite the canonical profile. /brand-wiki/genome-and-company-south-korea · Editorial policy · How profiles are compiled